Drug Shortage Report for ACH-APIXABAN
Report ID | 177033 |
Drug Identification Number | 02487721 |
Brand name | ACH-APIXABAN |
Common or Proper name | APIXABAN |
Company Name | ACCORD HEALTHCARE INC |
Market Status | MARKETED |
Active Ingredient(s) | APIXABAN |
Strength(s) | 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL |
Packaging size | 60 |
ATC code | B01AF |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-02 |
Estimated end date | |
Actual end date | 2023-01-23 |
Shortage status | Resolved |
Updated date | 2023-01-24 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Company contact information | Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2023-01-24 | English | Compare |
v7 | 2023-01-13 | French | Compare |
v6 | 2023-01-13 | English | Compare |
v5 | 2022-12-19 | French | Compare |
v4 | 2022-12-19 | English | Compare |
v3 | 2022-12-03 | English | Compare |
v2 | 2022-12-02 | French | Compare |
v1 | 2022-12-02 | English | Compare |
Showing 1 to 8 of 8